St. Jude Medical, Atrial Fibrillation Division, Inc. recalls TactiFlex Ablation Sensor Enabled Ablation Catheter, Models A-TFSE-FJ, 7.5 F shaft and an 8F distal section, Sterile.
- Recall date
- December 18, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0814-2024
- FDA classification
- Class II
- Brand / firm
- St. Jude Medical, Atrial Fibrillation Division, Inc.
- Sold / distributed
- Worldwide - US Nationwide distribution including in the states of AL, AZ, CA, CO, DC, DE, FL, GA, IA, IL, KS, MA, MD, MI, MN, MO, MS, MT, NC, NE, NJ, NV, NY, OH, PA, SC, TN, TX, UT, VA, WA, and WV. The country of Canada.
Why it was recalled
When the catheters are used with the EnSiteX EP System, the system does not correctly recognize the catheter as the appropriate product model and instead reads and displays it as a different model. This results in some features specific to the catheter do not appear on the display and the catheter image may also appear inverted.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
TactiFlex Ablation Sensor Enabled Ablation Catheter, Models A-TFSE-FJ, 7.5 F shaft and an 8F distal section, Sterile.
Get recall alerts
Free email alert whenever St. Jude Medical, Atrial Fibrillation Division, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: St. Jude Medical, Atrial Fibrillation Division, Inc.